A patient with pulmonary metastatic extraskeletal myxoid chondrosarcoma (EMC), of unknown cause, responded dramatically to 16 months of therapy with interferon alfa-2b. This is the first report of a significant response of a patient with EMC to this novel treatment approach.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1378/chest.108.1.281 | DOI Listing |
Publication Analysis
Top Keywords
metastatic extraskeletal
8
extraskeletal myxoid
8
myxoid chondrosarcoma
8
therapy interferon
8
interferon alfa-2b
8
chondrosarcoma successful
4
successful therapy
4
alfa-2b patient
4
patient pulmonary
4
pulmonary metastatic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!